Antibody specificity and off-target testing
Up to a third of all lead candidate antibodies display off-target binding.
De-risk expensive late-stage failures with cost effective early off-target testing during lead selection.
We express each ectodomain in human cells, purify, and validate on a gel so you can be sure it has been tested.
Essential Features for Reliable Antibody Screening
High-Quality Human Receptor Arrays
Test against validated human receptor ectodomains expressed in human cells, ensuring real-world relevance
Proactive Off-Target Detection
Identify potential off-target interactions early, minimising costly failures and enhancing clinical trial readiness
Cost-Effective, Scalable Testing
Our platform provides scalable testing solutions, making it feasible to screen a high number of leads efficiently.
